Macamides as Potential Therapeutic Agents in Neurological Disorders
Karin J Vera-López1, Gonzalo Davila-Del-Carpio1, Rita Nieto-Montesinos1
1Escuela Profesional de Farmacía y Bioquímica, Universidad Católica de Santa María, Urb. San José s/n-Umacollo, Arequipa 04000, Peru.
Macamides, derived from the Peruvian Maca plant (Lepidium meyenii), show promise for treating neurological disorders due to their neuroprotective and antioxidant properties. Further research explores their therapeutic potential and metabolic pathways.
Area of Science:
- Pharmacology
- Neuroscience
- Ethnobotany
Background:
- Nervous system disorders present significant therapeutic challenges.
- Advances enable precise identification of drug targets for neurological conditions.
- Maca (Lepidium meyenii), a Peruvian plant, is explored for its metabolites' therapeutic effects.
Purpose of the Study:
- To review the therapeutic potential of macamides, metabolites from Maca.
- To discuss macamides as potential treatments for neurological disorders.
- To explore the metabolic pathways influenced by macamides.
Main Methods:
- Literature review of studies on Maca metabolites, specifically macamides.
- Analysis of research on neuroprotective, antioxidant, and immune-enhancing properties.
- Examination of proposed mechanisms of action and metabolic pathways.
Main Results:
- Macamides are N-benzylamides of long-chain fatty acids found in Maca.
- They exhibit neuroprotective, antioxidant, and immune-enhancing effects.
- Macamides demonstrate excellent human tolerance and low toxicity.
Conclusions:
- Macamides are promising therapeutic agents for neurological disorders.
- Their properties support their development as neuroprotective drugs.
- Further investigation into their metabolic pathways is warranted.
More Related Videos
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
09:52Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Published on: February 23, 2020
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiepileptic Drugs: Glutamate Antagonists
Alzheimer's Disease: Treatment
Drugs Affecting Neurotransmitter Release or Uptake
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drugs Affecting Neurotransmitter Synthesis
